Related Experiment Video
Updated: Jun 4, 2025

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
Published on: December 17, 2010
Update on Autoimmune Pancreatitis and IgG4-Related Disease
Marco Lanzillotta1,2, Miroslav Vujasinovic3,4, Johannes-Matthias Löhr3,4
1IRCCS San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan, Italy.
Autoimmune pancreatitis has two subtypes: Type 1, linked to IgG4-related disease, and Type 2, associated with inflammatory bowel diseases. Treatment primarily uses glucocorticoids, with maintenance therapy for Type 1 due to higher relapse rates.
Area of Science:
- Gastroenterology
- Immunology
- Pathology
Background:
- Autoimmune pancreatitis (AIP) is an inflammatory condition of the pancreas.
- Two subtypes exist: Type 1 (lymphoplasmacytic) and Type 2 (neutrophilic).
- Type 1 AIP is a manifestation of IgG4-related disease; Type 2 AIP is pancreas-specific and linked to inflammatory bowel diseases.
Purpose of the Study:
- To review the key concepts of autoimmune pancreatitis.
- To differentiate between the two subtypes of AIP.
- To discuss recent research and unmet needs in AIP management.
Main Methods:
- Literature review of autoimmune pancreatitis.
- Analysis of diagnostic criteria including imaging, laboratory, and histology.
- Summary of current treatment strategies and outcomes.
Main Results:
- Type 1 AIP is associated with elevated IgG4 levels and fibro-inflammatory changes.
- Type 2 AIP is a distinct entity often co-occurring with inflammatory bowel diseases.
- Glucocorticoids are the primary treatment, with other immunosuppressants used for refractory cases.
Conclusions:
- Accurate diagnosis requires comprehensive evaluation to distinguish AIP subtypes and rule out malignancy.
- Treatment strategies vary, with maintenance therapy crucial for Type 1 AIP due to recurrence risk.
- Further research is needed to address unmet needs in autoimmune pancreatitis management.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...

